Yi, Y.W.; You, K.S.; Han, S.; Ha, I.J.; Park, J.-S.; Lee, S.-G.; Seong, Y.-S.
Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. Cancers 2022, 14, 5215.
https://doi.org/10.3390/cancers14215215
AMA Style
Yi YW, You KS, Han S, Ha IJ, Park J-S, Lee S-G, Seong Y-S.
Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. Cancers. 2022; 14(21):5215.
https://doi.org/10.3390/cancers14215215
Chicago/Turabian Style
Yi, Yong Weon, Kyu Sic You, Sanghee Han, In Jin Ha, Jeong-Soo Park, Seok-Geun Lee, and Yeon-Sun Seong.
2022. "Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells" Cancers 14, no. 21: 5215.
https://doi.org/10.3390/cancers14215215
APA Style
Yi, Y. W., You, K. S., Han, S., Ha, I. J., Park, J.-S., Lee, S.-G., & Seong, Y.-S.
(2022). Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. Cancers, 14(21), 5215.
https://doi.org/10.3390/cancers14215215